Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Reported Basic Consolidated EPS Of $-0.534 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Synta Pharmaceuticals Corp. (NASDAQ:SNTA) for the period ended 2015-12-31 was $-0.534. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-0.534.

EPS from continuing operations

Coming to basic EPS from continuing operations, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) reported $-0.534 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-0.534.

EPS contribution from parent

For the annual period ended 2015-12-31, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) received basic EPS of $-0.534 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-0.534.

Basic net EPS

For the annual period ended 2015-12-31, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) reported basic net EPS of $-0.53. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-0.53.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-0.534. For the quarter ended 2015-12-31, consolidated diluted EPS was $-0.534.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.534 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-0.534.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-0.53. For the quarterly period ended 2015-12-31, net diluted EPS was $-0.53.

Diluted EPS from parent

From the parent company, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) received diluted EPS of $-0.534 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-0.534.

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) posted net basic EPS reading of $-0.53 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-0.53 was for the quarter ended 2015-12-31.

Net diluted EPS for Synta Pharmaceuticals Corp. (NASDAQ:SNTA) for the annual period ended 2015-12-31 was $-0.53. The company also reported net diluted EPS reading of $-0.53 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 128.595 while for the quarter ended 2015-12-31 is 128.595.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 128.595 while for the quarter ended 2015-12-31 is 128.595.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 10 times, 1 visits today)